NCT01875237 · OUTCOME

To Assess Post Donor Lymphocyte Infusion (DLI) Chimerism

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene · Source last updated 2019-07-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

What was measured

To assess the number of Participants with 100% donor chimerism at 6 months post donor lymphocyte infusion (DLI)

Analysis population: patients who received DLI

Patients who did not move forward to DLI

Proceeded to DLI per protocol and developed GVHD

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Transplant Only	0
Transplat Plus DLI	1

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Transplant Only	0	Not reported	Not reported	Not reported	Not reported
Transplat Plus DLI	1	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

denoms

description

To assess the number of Participants with 100% donor chimerism at 6 months post donor lymphocyte infusion (DLI)

groups

param Type

COUNT_OF_PARTICIPANTS

population Description

patients who received DLI

reporting Status

POSTED

time Frame

6 months

title

To Assess Post Donor Lymphocyte Infusion (DLI) Chimerism

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice